vs
ARDELYX, INC.（ARDX）与DOMO, INC.（DOMO）财务数据对比。点击上方公司名可切换其他公司
ARDELYX, INC.的季度营收约是DOMO, INC.的1.2倍（$94.5M vs $79.4M），DOMO, INC.净利率更高（-13.1% vs -39.8%，领先26.7%），ARDELYX, INC.同比增速更快（27.5% vs -0.5%），过去两年ARDELYX, INC.的营收复合增速更高（13.6% vs -0.5%）
Ardelyx是一家商业化阶段的生物制药企业，专注于研发和商业化针对胃肠道、心肾及代谢类疾病的创新疗法，其核心产品已在美国获批用于治疗便秘型肠易激综合征，同时拥有涵盖多适应症的各阶段研发管线。
Domo股份有限公司是总部设在美国犹他州美国福克的美国云软件企业，主营人工智能、商业智能与数据可视化业务，属于SaaS（软件即服务）企业，核心产品可帮助企业各层级决策者在极少IT介入的情况下，实时获取业务数据，支撑决策开展。
ARDX vs DOMO — 直观对比
营收规模更大
ARDX
是对方的1.2倍
$79.4M
营收增速更快
ARDX
高出27.9%
-0.5%
净利率更高
DOMO
高出26.7%
-39.8%
两年增速更快
ARDX
近两年复合增速
-0.5%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $94.5M | $79.4M |
| 净利润 | $-37.6M | $-10.4M |
| 毛利率 | — | 74.2% |
| 营业利润率 | — | -8.7% |
| 净利率 | -39.8% | -13.1% |
| 营收同比 | 27.5% | -0.5% |
| 净利润同比 | — | 44.6% |
| 每股收益（稀释后） | $-0.15 | $-0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARDXDOMO
| Q1 26 | $94.5M | — | ||
| Q4 25 | $125.2M | $79.4M | ||
| Q3 25 | $110.3M | $79.7M | ||
| Q2 25 | $97.7M | $80.1M | ||
| Q1 25 | $74.1M | $78.8M | ||
| Q4 24 | $116.1M | $79.8M | ||
| Q3 24 | $98.2M | $78.4M | ||
| Q2 24 | $73.2M | $80.1M |
净利润ARDXDOMO
| Q1 26 | $-37.6M | — | ||
| Q4 25 | $-407.0K | $-10.4M | ||
| Q3 25 | $-969.0K | $-22.9M | ||
| Q2 25 | $-19.1M | $-18.1M | ||
| Q1 25 | $-41.1M | $-17.7M | ||
| Q4 24 | $4.6M | $-18.8M | ||
| Q3 24 | $-809.0K | $-19.5M | ||
| Q2 24 | $-16.5M | $-26.0M |
毛利率ARDXDOMO
| Q1 26 | — | — | ||
| Q4 25 | 91.3% | 74.2% | ||
| Q3 25 | 96.4% | 74.8% | ||
| Q2 25 | 87.3% | 74.2% | ||
| Q1 25 | 83.4% | 74.4% | ||
| Q4 24 | 84.3% | 75.0% | ||
| Q3 24 | 84.0% | 74.3% | ||
| Q2 24 | 87.1% | 74.1% |
营业利润率ARDXDOMO
| Q1 26 | — | — | ||
| Q4 25 | 4.1% | -8.7% | ||
| Q3 25 | 4.2% | -9.1% | ||
| Q2 25 | -14.7% | -17.9% | ||
| Q1 25 | -49.0% | -15.6% | ||
| Q4 24 | 7.0% | -13.9% | ||
| Q3 24 | 2.3% | -18.5% | ||
| Q2 24 | -18.6% | -26.8% |
净利率ARDXDOMO
| Q1 26 | -39.8% | — | ||
| Q4 25 | -0.3% | -13.1% | ||
| Q3 25 | -0.9% | -28.8% | ||
| Q2 25 | -19.5% | -22.5% | ||
| Q1 25 | -55.5% | -22.4% | ||
| Q4 24 | 4.0% | -23.5% | ||
| Q3 24 | -0.8% | -24.9% | ||
| Q2 24 | -22.5% | -32.5% |
每股收益（稀释后）ARDXDOMO
| Q1 26 | $-0.15 | — | ||
| Q4 25 | $-0.01 | $-0.25 | ||
| Q3 25 | $0.00 | $-0.56 | ||
| Q2 25 | $-0.08 | $-0.45 | ||
| Q1 25 | $-0.17 | $-0.45 | ||
| Q4 24 | $0.01 | $-0.48 | ||
| Q3 24 | $0.00 | $-0.51 | ||
| Q2 24 | $-0.07 | $-0.69 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $238.1M | — |
| 总债务越低越好 | $203.5M | $124.2M |
| 股东权益账面价值 | $148.6M | $-191.9M |
| 总资产 | $504.5M | $201.6M |
| 负债/权益比越低杠杆越低 | 1.37× | — |
8季度趋势，按日历期对齐
现金及短期投资ARDXDOMO
| Q1 26 | $238.1M | — | ||
| Q4 25 | $68.0M | — | ||
| Q3 25 | $42.7M | — | ||
| Q2 25 | $90.0M | $47.2M | ||
| Q1 25 | $30.8M | $45.3M | ||
| Q4 24 | $64.9M | — | ||
| Q3 24 | $47.4M | — | ||
| Q2 24 | $41.9M | $61.2M |
总债务ARDXDOMO
| Q1 26 | $203.5M | — | ||
| Q4 25 | $202.8M | $124.2M | ||
| Q3 25 | $202.1M | $121.9M | ||
| Q2 25 | $201.4M | $119.7M | ||
| Q1 25 | $151.3M | $117.7M | ||
| Q4 24 | $150.9M | $115.6M | ||
| Q3 24 | $100.7M | $115.2M | ||
| Q2 24 | $100.2M | $114.1M |
股东权益ARDXDOMO
| Q1 26 | $148.6M | — | ||
| Q4 25 | $166.9M | $-191.9M | ||
| Q3 25 | $154.3M | $-191.5M | ||
| Q2 25 | $139.5M | $-178.7M | ||
| Q1 25 | $145.7M | $-177.2M | ||
| Q4 24 | $173.3M | $-171.2M | ||
| Q3 24 | $158.3M | $-166.4M | ||
| Q2 24 | $147.0M | $-163.5M |
总资产ARDXDOMO
| Q1 26 | $504.5M | — | ||
| Q4 25 | $501.6M | $201.6M | ||
| Q3 25 | $486.2M | $195.7M | ||
| Q2 25 | $466.8M | $189.7M | ||
| Q1 25 | $410.2M | $214.3M | ||
| Q4 24 | $435.8M | $190.2M | ||
| Q3 24 | $367.9M | $197.8M | ||
| Q2 24 | $343.5M | $204.4M |
负债/权益比ARDXDOMO
| Q1 26 | 1.37× | — | ||
| Q4 25 | 1.21× | — | ||
| Q3 25 | 1.31× | — | ||
| Q2 25 | 1.44× | — | ||
| Q1 25 | 1.04× | — | ||
| Q4 24 | 0.87× | — | ||
| Q3 24 | 0.64× | — | ||
| Q2 24 | 0.68× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $3.4M |
| 自由现金流经营现金流 - 资本支出 | — | $1.1M |
| 自由现金流率自由现金流/营收 | — | 1.4% |
| 资本支出强度资本支出/营收 | — | 2.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $9.9M |
8季度趋势，按日历期对齐
经营现金流ARDXDOMO
| Q1 26 | — | — | ||
| Q4 25 | $21.0M | $3.4M | ||
| Q3 25 | $365.0K | $3.4M | ||
| Q2 25 | $-25.3M | $4.0M | ||
| Q1 25 | $-38.5M | $8.9M | ||
| Q4 24 | $9.8M | $-13.7M | ||
| Q3 24 | $501.0K | $-6.2M | ||
| Q2 24 | $-19.4M | $1.9M |
自由现金流ARDXDOMO
| Q1 26 | — | — | ||
| Q4 25 | $20.6M | $1.1M | ||
| Q3 25 | $209.0K | $1.0M | ||
| Q2 25 | $-26.0M | $1.0M | ||
| Q1 25 | $-38.8M | $6.7M | ||
| Q4 24 | $9.2M | $-16.2M | ||
| Q3 24 | $364.0K | $-8.4M | ||
| Q2 24 | $-19.5M | $-625.0K |
自由现金流率ARDXDOMO
| Q1 26 | — | — | ||
| Q4 25 | 16.4% | 1.4% | ||
| Q3 25 | 0.2% | 1.3% | ||
| Q2 25 | -26.6% | 1.3% | ||
| Q1 25 | -52.3% | 8.5% | ||
| Q4 24 | 7.9% | -20.3% | ||
| Q3 24 | 0.4% | -10.7% | ||
| Q2 24 | -26.7% | -0.8% |
资本支出强度ARDXDOMO
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 2.9% | ||
| Q3 25 | 0.1% | 2.9% | ||
| Q2 25 | 0.7% | 3.7% | ||
| Q1 25 | 0.4% | 2.8% | ||
| Q4 24 | 0.5% | 3.2% | ||
| Q3 24 | 0.1% | 2.8% | ||
| Q2 24 | 0.2% | 3.2% |
现金转化率ARDXDOMO
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.11× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARDX
| IBSRELA | $70.1M | 74% |
| XPHOZAH | $23.3M | 25% |
| Non-cash royalty revenue related to the sale of future royalties | $695.0K | 1% |
| Product supply revenue | $354.0K | 0% |
DOMO
| Subscription | $71.9M | 91% |
| Professional Servicesand Other | $7.5M | 9% |
